Verona Pharma plc
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
30.18 |
344.88 |
626.36 |
1,004.36 |
1,408.98 |
1,794.34 |
| Przychód Δ r/r |
0.00% |
1042.92% |
81.62% |
60.35% |
40.29% |
27.35% |
| Przychód (min) |
30.08 |
222.94 |
471.24 |
962.74 |
1,076.11 |
1,370.43 |
| Przychód (max) |
30.36 |
396.64 |
760.54 |
1,045.98 |
1,674.49 |
2,132.47 |
| EBITDA (średnia) |
-6.04 |
-68.98 |
-125.27 |
-200.87 |
-281.80 |
-358.87 |
| EBIT (średnia) |
-6.04 |
-68.98 |
-125.27 |
-200.87 |
-281.80 |
-358.87 |
| EBIT % |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-16.57 |
10.87 |
49.58 |
172.08 |
213.24 |
288.69 |
| Zysk netto % |
-54.92% |
3.15% |
7.92% |
17.13% |
15.13% |
16.09% |
| EPS (średnia) |
-0.20 |
0.13 |
0.61 |
2.25 |
2.62 |
3.54 |
| Liczba analityków (Przychody) |
7 |
7 |
10 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
5 |
3 |
4 |
3 |
1 |
1 |
| symbol |
VRNA |
VRNA |
VRNA |
VRNA |
VRNA |
VRNA |